Lateral Flow Immunoassay (LFIA) Based Rapid Test Market 2022 – By Technique (Competitive Assay, Sandwich Assay, Multiplex Detection Assay), By Application (Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care), And By Region, Opportunities And Strategies – Global Forecast To 2031

Starting Price : $5000.00 | Pages : 248 | Published : June 2022 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

LFIA Based Rapid Test Market Definition

The LFIA based rapid test market consists of sales of LFIA based rapid test equipment used to run lateral flow immunoassays LFIA based rapid test and related services by companies that develop LFIA based rapid test equipment. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples of urine, blood or saliva obtained from the human body.

Lateral flow immunoassays are simple cellulose-based assays that detect the presence of a target analyte such as pathogens or biomarkers in samples, where preliminary screening tests is required without using specialized equipment. These tests are widely used for point of care testing including for infectious disease, pregnancy and fertility, toxicology, and other applications. In the test, the sample of urine, blood or saliva is added to the test device and it flows through the conjugate pad then onto the absorbent pad into the nitrocellulose membrane. These are performed by trained lay users, professionals, or a patient in laboratory, clinics or home setting. These tests are designed to require minimal training to operate.

LFIA Based Rapid Test Market Size

The global LFIA based rapid test market size reached a value of nearly $11,050.8 million in 2021, having increased at a compound annual growth rate (CAGR) of 14.5% since 2016. The global LFIA based rapid test market size is expected to decline from $11,050.8 million in 2021 to $6,836.7 million in 2026 at a rate of -9.2%. The global LFIA based rapid test market size is then expected to grow at a CAGR of 6.9% from 2026 and reach $9,542.8 million in 2031.  

Growth in the historic period in the LFIA based rapid test market resulted from increased cases of infectious diseases, rising demand for point-of-care testing under home care settings, increased healthcare expenditure, and emerging markets growth. The market was restrained by regulatory challenges, political uncertainties, reduction in free trade, inconsistent results of lateral flow assays tests, recalls of product due to false results, and low healthcare reimbursements.

Going forward, an increase in healthcare access, the COVID-19 pandemic, rising ageing population, growing demand for home-based lateral flow assays devices, easy accessibility, and increasing regulatory approvals will drive the market in future. Factors that could hinder the growth of the market in the future include lack of skilled labor, strict government regulations for approvals of rapid tests, and low sensitivity of rapid tests.

LFIA Based Rapid Test Market Drivers

The key drivers of the LFIA based rapid test market include:

Growing Demand for Home-Based Lateral Flow Assay Devices

The growing demand for home-based lateral flow assay devices in expected to support the LFIA based rapid test market in the forecast period. Home-based lateral flow assays devices are diagnostic equipment used to confirm the presence or absence of a target analyte in humans or animals, such as infections or biomarkers, or pollutants in water sources, foodstuffs, or animal feeds. They are frequently used to test pregnancy and stigmatized conditions such as HIV, as they can be conducted at home. Many firms created home-based lateral flow assays for COVID-19 testing during COVID-19 pandemic as individuals were terrified of being tested at diagnostic laboratories or hospitals. This fueled the need for home-based lateral flow tests thus driving the market. As a result, various home-based tests were developed. For instance, in 2021, Novacyt, a biotech company focusing on clinical diagnostics, launched two antigen lateral flow tests that small, instrument-free, and include all of the components needed for safe sample collection, preparation, testing, result interpretation, and disposal for use by healthcare professionals or patients at home. The increasing demand for home-based lateral flow assays devices are expected to boost the growth of the market.

LFIA Based Rapid Test Market Restraints

The key restraints on the LFIA based rapid test market include:

Low Sensitivity Of Rapid Tests

The low sensitivity of LFIA based rapid tests are expected to hamper the growth of the market. According to a study conducted by NCBI in May 2021, a total of 148 nasopharyngeal swabs were examined. The rapid antigen test detected 32 of the 106 positive RT-qPCR samples, giving an overall sensitivity of 30.2 percent. The overall low sensitivity rate of rapid tests alone as frontline testing is not considered to be reliable. Such poor sensitivity rate is expected to hamper the growth of the market.

LFIA Based Rapid Test Market Trends

Major trends shaping the LFIA based rapid test market include:

Technological Advancements

Technological advancements are a key driver in the LFIA based rapid test market. Companies are gradually increasing innovation in lateral flow assay-based Point of Care (PoC) devices for applications such as pregnancy testing, ovulation monitoring, screening for infectious diseases and drugs of abuse, and the measurement of protein markers in the blood to aid rapid clinical diagnostics of life-threatening events (such as heart attacks, strokes, and deep-vein thrombosis). For instance, in February 2021, Canadian firm Laipac Technology, a leading company in the development of Telehealth and Internet of Medical Things (IoMT) products and solutions, announced the partnership with United Arab Emirates companies. The European CE-IVD approved LooK SPOT AI COVID-19 Antigen Rapid Test System. This is a smartphone-based diagnostic device with lateral flow immunoassay, intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasal swabs. The LooK SPOT artificial intelligence ecosystem modernizes medical diagnostics, allowing initial disease detection with consistent and accurate results.

Artificial Intelligence Based Tests

The adoption of artificial intelligence is an emerging trend in the LFIA based rapid test market. Recent developments in artificial intelligence (AI) have had a significant impact on the healthcare industry. The use of artificial intelligence (AI) in the industry saves time and reduces research and development costs. AI algorithms are effective in streamlining infectious diseases screening and detection. For instance, in 2020, Mendels applied AI to increase test result explanations of conventional LFIA assay for COVID-19 detection, by creating a smartphone app, xRCovid, which mostly deleted human errors using machine learning. Finally, they claimed that this app achieved 99.3% precision compared to eye reading and is therefore beneficial for POC testing in the future.

Opportunities And Recommendations In The LFIA Based Rapid Test Market

Opportunities –The top opportunities in the LFIA based rapid test market segmented by technique will arise in multiplex detection assay segment, which will gain $405.0 million of global annual sales by 2026. The top opportunities in the LFIA based rapid test market segmented by end-users will arise in other end users segment, which will gain $(242.5) million of global annual sales by 2026. The top opportunities in the LFIA based rapid test market segmented by application will arise in other applications segment, which will gain $180.5 million of global annual sales by 2026. The LFIA based rapid test market size will gain the most in the Indonesia at $41.9 million.

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the LFIA based rapid test companies to focus on strategic collaborations and partnerships, focus on artificial intelligence-based tests, invest in technological advancements, expand in developed markets, expand in countries with growing elderly population, adopt market-based pricing, provide competitively priced offerings, participate in trade shows and events, leverage social media and focus on collaborating with hospitals.

LFIA Based Rapid Test Market Segmentation

The LFIA based rapid test market is segmented by technique, by end-users and by application.
By Technique –
The LFIA based rapid test market is segmented by technique into
    • a) Competitive Assay
    • b) Sandwich Assay
    • c) Multiplex Detection Assay
The sandwich assay segment was the largest segment of the LFIA based rapid test market segmented by technique, accounting for 70.6% of the total in 2021. Going forward, the sandwich assay segment is expected to be the fastest growing segment in the LFIA based rapid test market segmented by technique, at a CAGR of -8.8% during 2021-2026.
By End-Users –
The LFIA based rapid test market is segmented by end-users into
    • a) Hospitals And Clinics
    • b) Diagnostic Laboratories
    • c) Home Care
    • d) Others
The hospitals and clinics segment was the largest segment of the LFIA based rapid test market segmented by end-users, accounting for 43.0% of the total in 2021. Going forward, other end users segment is expected to be the fastest growing segment in the LFIA based rapid test market segmented by end-users, at a CAGR of -8.6% during 2021-2026.
By Application –
The LFIA based rapid test market is segmented by application into
    • a) Infectious Disease
    • b) Pregnancy And Fertility
    • c) Toxicology
    • d) Cardiac Marker And Cholesterol Testing
    • e) Others
The cardiac marker and cholesterol testing segment was the largest segment of the LFIA based rapid test market segmented by application, accounting for 38.4% of the total in 2021. Going forward, other applications segment is expected to be the fastest growing segment in the LFIA based rapid test market segmented by application, at a CAGR of -7.7% during 2021-2026.
By Geography- The LFIA based rapid test market is segment by geography into
    • o Asia Pacific
      • •  China
      • •  Japan
      • •  India
      • •  Australia
      • •  Indonesia
      • •  South Korea
      • o North America
      • • USA
      o South America
      • • Brazil 
      o Western Europe
      • • UK 
      • • Germany 
      • • France 
      o Eastern Europe
      • • Russia 
      o Middle East
      o Africa
North America was the largest region in the global LFIA based rapid test market, accounting for 37.5% of the total in 2021. It was followed by the Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the global LFIA based rapid test market will be Africa and Middle East where growth will be at CAGRs of -7.1% and -8.1% respectively during 2021-2026. These will be followed by North America and Western Europe, where the markets are expected to register CAGRs of -8.5% and -8.6% respectively during 2021-2026.

LFIA Based Rapid Test Market Competitive Landscape

Major Competitors are:

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Quidel Corporation
  • Becton, Dickinson and Company
  • Danaher Corporation

    • Other Competitors Include:

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO Biotechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio Biotechnology Systems
  • Elabscience® Immunoassay Kits
  • FyoniBio / Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh
  • BIOMED Labordiagnostik GmbH
  • Charles River Laboratories
  • EKF Diagnostics
  • Launch Diagnostics
  • Diagnostic Instruments Ltd
  • Qiagen N.V.
  • Merck KGaA
  • XPhyto Therapeutics
  • 3a Diagnostics
  • BATM
  • Biomaxima
  • SensDx
  • Vitrosens Biotechnology
  • Bioeasy Biotechnology
  • Fujirebio
  • Immunodiagnostic Systems Holdings PLC
  • Mesa Biotech Inc
  • CTK Biotech
  • Wamadiagnostica
  • Marksans Pharma Ltd
  • Lana Al Khaleej
  • Natejah Medical Supplies
  • Synlab
  • K2 Medical’s
  • SA Biomedical Group

      • Table Of Contents

      1. LFIA Based Rapid Test Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Technique

      6.3. Segmentation By End-User

      6.4. Segmentation By Application

      7. LFIA Based Rapid Test Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Technique

      7.2.1. Competitive Assay

      7.2.2. Sandwich Assay

      7.2.3. Multiplex Detection Assay

      7.3. Segmentation By End-Users

      7.3.1. Hospitals And Clinics

      7.3.2. Diagnostic Laboratories

      7.3.3. Home Care

      7.3.4. Other End Users

      7.4. Segmentation By Application

      7.4.1. Infectious Disease

      7.4.2. Pregnancy And Fertility

      7.4.3. Toxicology

      7.4.4. Cardiac Marker And Cholesterol Testing

      7.4.5. Other Applications

      8. LFIA Based Rapid Test Market Trends And Strategies

      8.1. Technological Advancements

      8.2. Partnerships And Collaborations

      8.3. At Home Test Kits

      8.4. Artificial Intelligence Based Tests

      8.5. Affordable Or Low-Cost Test Kits

      9. Impact Of COVID-19 On The LFIA Based Rapid Test Market

      9.1. Government Investments In Rapid Test

      9.2. Impact On Manufacturers

      9.3. Impact Of Virus Mutations On The Rapid Test Kits Market

      9.4. Future Outlook

      10. Global LFIA Based Rapid Test Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of The Market 2016-2021

      10.2.2. Restraints On The Market 2016-2021

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021-2026

      10.3.2. Restraints On The Market 2021-2026

      11. Global LFIA Based Rapid Test Market Segmentation

      11.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. LFIA Based Rapid Test Market, Regional And Country Analysis

      12.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.1. Asia-Pacific LFIA Based Rapid Test Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis

      13.6. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.7. China LFIA Based Rapid Test Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Background Information

      13.7.4. Government Initiatives

      13.7.5. Regulations

      13.7.6. Regulatory Bodies

      13.7.7. Major Associations

      13.7.8. Taxes Levied

      13.7.9. Corporate Tax Structure

      13.7.10. Investments

      13.7.11. Major Companies

      13.8. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.10. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.11. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.12. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.13. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.14. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.15. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.16. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.17. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.18. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.19. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.20. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.21. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.22. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.23. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.24. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.25. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.26. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      13.28. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.29. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.30. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      14.1. Western Europe LFIA Based Rapid Test Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis

      14.6. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      14.7. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.8. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.9. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.10. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      14.11. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.12. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.13. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.14. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      14.15. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.16. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.17. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      15.1. Eastern Europe LFIA Based Rapid Test Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis

      15.6. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      15.7. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.8. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.9. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      16.1. North America LFIA Based Rapid Test Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis

      16.6. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      16.7. US LFIA Based Rapid Test Market Overview

      16.7.1. Country Information

      16.7.2. Market Information

      16.7.3. Background Information

      16.7.4. Government Initiatives

      16.7.5. Regulations

      16.7.6. Regulatory Bodies

      16.7.7. Major Associations

      16.7.8. Taxes Levied

      16.7.9. Corporate Tax Structure

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.9. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.10. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      17.1. South America LFIA Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis

      17.6. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      17.7. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.8. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.9. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      18.1. Middle East LFIA Based Rapid Test Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

      19.1. Africa LFIA Based Rapid Test Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. LFIA Based Rapid Test Global Market Competitive Landscape

      20.1. Company Profiles

      20.2. Abbott Laboratories

      20.2.1. Company Overview

      20.2.2. Products And Services.

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. F. Hoffmann-La Roche

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Quidel Corporation

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Becton, Dickinson and Company

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Danaher Corporation

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Global LFIA Based Rapid Test Market

      21.1. Becton, Dickinson and Company Acquired Scanwell Health

      21.2. DiaSorin Acquired Luminex Corporation For $1.8 Billion

      21.3. PerkinElmer Inc. Acquired Immunodiagnostic Systems Holdings PLC

      21.4. Hologic Inc. Acquired Mobidiag

      21.5. Thermo Fisher Acquired Mesa Biotech Inc.

      21.6. Qiagen N.V. Acquired NeuMoDx Molecular, Inc.

      21.7. BioMérieux SA Acquired Suzhou Hybiome Biomedical Engineering Co.Ltd.

      22. LFIA Based Rapid Test Market Opportunities And Strategies

      22.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2026 – Countries Offering Most New Opportunities

      22.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2026 – Segments Offering Most New Opportunities

      22.3. Global LFIA Based Rapid Test Market In 2026 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. LFIA Based Rapid Test Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 14: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 17: Asia-Pacific Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 18: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 19: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 20: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 21: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 22: China GDP Per Capita, 2015-2020, $
    • Table 23: China, Population By Age Group, 2015-2025, Thousands
    • Table 24:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 25: China Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 26: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 27: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 28: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 29: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 30: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 31: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 32: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 33: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 34: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 35: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 36: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 39: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 40: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 41: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 42: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 43: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 44: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 47: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 48: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 49: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 50: Western Europe GDP Per Capita, 2015-2020, $
    • Table 51: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 52:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 53:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 54: Western Europe Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 55: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 56: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 57: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 58: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 59: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 60: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 61: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 62: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 63: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 64: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 65: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 66: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 67: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 68: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 69: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 70: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 71: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 72: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 73:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 74:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 75: Eastern Europe Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 76: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 77: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 78: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 81: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 82: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 83: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 84: North America GDP Per Capita, 2015-2020, $
    • Table 85: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 86:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 87:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 88: North America Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 89: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 90: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 91: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 92: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 93: USA GDP Per Capita, 2015-2020, $
    • Table 94: USA, Population By Age Group, 2015-2025, Thousands
    • Table 95:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 96: USA Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 97: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 98: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 99: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 100: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 101: South America GDP Per Capita, 2015-2020, $
    • Table 102: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 103:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 104:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 105: South America Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 106: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 107: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 108: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 109: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 110: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 111: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 112: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 113: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 114: Middle East GDP Per Capita, 2015-2020, $
    • Table 115: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 116:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 117:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 118: Middle East Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 119: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 120: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 121: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 122: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 123: Africa GDP Per Capita, 2015-2020, $
    • Table 124: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 125:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 126:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 127: Africa Healthcare Services Market Size, 2016-2026, $ Billion
    • Table 128: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Table 129: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 130: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 131: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 132: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 133: Abbott Laboratories – Financial Performance, 2016 – 2020, $ Billion
    • Table 134: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 135: Quidel Corporation – Financial Performance, 2016 – 2020, $ Billion
    • Table 136: Becton, Dickinson and Company – Financial Performance, 2016 – 2020, $ Billion
    • Table 137: Danaher Corporation Financial Performance, 2016 - 2020, $ Billion
    • Table 138: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 139: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size Gain ($ Million), Segmentation By Technique, 2021 – 2026
    • Table 140: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size Gain ($ Million), Segmentation By End-User, 2021 – 2026
    • Table 141: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
    • Table 142: Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Data Sources

    List Of Figures

      Figure 1: Global LFIA Based Rapid Test Market Segmentation By Technique
    • Figure 2: Global LFIA Based Rapid Test Market Segmentation By End-User
    • Figure 3: Global LFIA Based Rapid Test Market Segmentation By Application
    • Figure 4: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 5: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 6: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 7: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 8: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 12: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 13: Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 15: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 16: China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 17: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 18: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 19: India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 20: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 21: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 22: Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 24: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 27: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 28: Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 29: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 30: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 31: South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 32: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 33: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 34: Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 36: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 37: UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 39: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 40: Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 41: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 42: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 43: France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 44: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 45: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 46: Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 48: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 49: Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 51: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 52: North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 53: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 54: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 55: USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 56: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 57: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 58: South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 60: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 61: Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 63: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 64: Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 65: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
    • Figure 66: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 67: Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 68: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 69: Abbott Laboratories – Financial Performance, 2016 – 2020, $ Billion
    • Figure 70: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 71: Quidel Corporation – Financial Performance, 2016 – 2020, $ Billion
    • Figure 72: Becton, Dickinson and Company – Financial Performance, 2016 – 2020, $ Billion
    • Figure 73: Danaher Corporation Financial Performance, 2016 - 2020, $ Billion
    Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
    Read More
    How Will The Nuclear Medicine Market Grow In 2022?
    Read More
    What Is The Pediatric Imaging Market Overview In 2022?
    Read More
    Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
    Read More
    Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Dental Services Market 2022 – By Type (General Dentistry, Oral Surgery, Orthodontics, Prosthodontics), By Type Of Procedure (Cosmetic Dentistry, Non-Cosmetic Dentistry), By End-User (Gender) (Male, Female), By Type Of Expenditure (Public, Private), And By Region, Opportunities And Strategies – Global Forecast To 2031 
    View Report
    Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Medical Billing Outsourcing Global Market Report 2024 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Value Based Care Payment Global Market Report 2024 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Telemedicine Services Global Market Report 2024 – By Type (Web-based, Cloud-based, On-premises), By Technology outlook (Real-Time Telemedicine Services, Store-And-Forward Telemedicine Services), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatalogy, Telecardiology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Robotic Surgery Services Global Market Report 2024 – By Component (Systems, Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopaedics Surgery, Neurosurgery And Other Applications), By End-Use (Hospitals And Ambulatory Surgery Centers (Ascs)) – Market Size, Trends, And Global Forecast 2024-2033
    View Report